Viewing nowRilont Tablet 35 mg (Risedronate Sodium)
Risedronate Sodium 35mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

MFDS item code 201310869 · Approved 2013.12.24 · Insurance code 640902430
Treatment and prevention of postmenopausal osteoporosis in women; treatment of osteoporosis in men
This medication is used for the treatment and prevention of osteoporosis in postmenopausal women and men.
1. Adults: Administer 35 mg of risedronate sodium orally once weekly. 2. Older adults: No dose adjustment is needed in older adults (over 60 years of age), because the bioavailability and pharmacodynamics of this medicine are similar to those in younger people. 4. Patients with renal impairment: No dose adjustment is needed in patients with creatinine clearance of 30 mL/min or greater. This medicine is contraindicated in patients with severe renal impairment and creatinine clearance less than 30 mL/min. ○ Food interferes with absorption of this medicine. For adequate absorption, take it at least 30 minutes before breakfast or at least 2 hours before or after consuming food or beverages at any time of day. To facilitate passage of this medicine into the stomach and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking this medicine with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take this medicine on the scheduled day, take it the next morning when remembered. Resume taking it on the originally scheduled day for the next dose. Do not take 2 tablets on the same day.
3. Children: Safety and efficacy have not been established in children under 18 years of age.
This medication may irritate the gastrointestinal mucosa, so individuals with diseases of the esophagus or stomach should be especially cautious. Severe symptoms such as esophagitis or esophageal ulcer may occur after taking, and if experiencing difficulty swallowing, pain behind the sternum, or heartburn, stop taking immediately and consult a doctor. This medication should be taken with sufficient water, and lying down for at least 30 minutes after ingestion should be avoided. It should particularly not be used by individuals with esophageal motility disorders, those who are pregnant, or those with severely impaired kidney function. Additionally, those with lactose intolerance should avoid taking this medication due to the lactose it contains. It is important to maintain adequate intake of calcium and vitamin D while taking this medication and to engage in appropriate exercise for bone health. Rare side effects such as osteonecrosis of the jaw or atypical fractures may occur, so any unusual symptoms should be reported to medical personnel immediately. When taking this medication with other drugs, absorption may be inhibited, so the timing of administration with calcium or antacids should be adjusted. Women who are pregnant or breastfeeding are advised not to use this medication, and safety for children has not been established. In case of an overdose, symptoms such as decreased blood calcium may appear, and immediate medical attention is necessary. This medication should be stored out of reach of children and should not be transferred to another container.
esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, bleeding, infection, low back pain, accidental injury, pain, abdominal pain, flu symptoms, headache, lethargy, throat pain, chest pain, allergic reaction, hypertension, constipation, diarrhea, dyspepsia, nausea, peripheral edema, arthralgia, arthritis, fracture, joint abnormalities, myalgia, bone pain, dizziness, depression, insomnia, bronchitis, sinusitis, rhinitis, pharyngitis, increased cough, rash, cataract, urinary tract infection, mucous membrane syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, Riel syndrome, angioedema, blister, skin reaction, osteonecrosis of the external auditory canal, iritis, uveitis, scleritis, jawbone necrosis, liver dysfunction, jaundice, loss of appetite, weakness, heartburn, epigastric pain, chest discomfort, palpitations, increased sweating, facial flushing, burning sensation, kidney stones, belching, hematuria, fever, eye pain
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in an airtight container to prevent air or moisture from entering, preferably at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness and prevents deterioration.
Pale orange oval film-coated tablet
4 tablets/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRisedronate Sodium 35mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

Risedronate Sodium 35mg
Tablet · Prescription medication
Yuyu Pharmaceutical Co., Ltd.

Risedronate Sodium 35mg
Tablet · Prescription medication
Guju Pharmaceutical Co., Ltd.

Risedronate Sodium 35mg
Tablet · Prescription medication
HK inno.N Co., Ltd.

Risedronate Sodium Monohydrate 37.07mg
Tablet · Prescription medication
Yuhan Corporation

Risedronate Sodium 35mg
Tablet · Prescription medication
IYON Pharmaceutical Co., Ltd.

Risedronate Sodium 35mg
Tablet · Prescription medication
Youngpoong Pharmaceutical Co., Ltd.

Risedronate Sodium Monohydrate 37.07mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.